Not applicableNot Yet RecruitingNCT07645742What this trial is testingPilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsWho this might be right forCancer (Advanced Stage) West Virginia University 90
Testing effectiveness (Phase 2)Looking for participantsNCT03667170What this trial is testingKN035 for dMMR/MSI-H Advanced Solid TumorsWho this might be right forSolid Tumor 3D Medicines (Sichuan) Co., Ltd. 200
Testing effectiveness (Phase 2)UnknownNCT04411524What this trial is testingThe Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal CancerWho this might be right forLocally Advanced Rectal Cancer Fudan University 50
Testing effectiveness (Phase 2)WithdrawnNCT04001101What this trial is testingAnti-PD-1 +/- RT for MSI-H Solid TumorsWho this might be right forMicrosatellite Instability HighMismatch Repair DeficiencyColorectal Cancer University of Colorado, Denver
Testing effectiveness (Phase 2)UnknownNCT04118933What this trial is testingPD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal CancerWho this might be right forColorectal Cancer Xu jianmin 40
Testing effectiveness (Phase 2)Looking for participantsNCT04114136What this trial is testingAnti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesWho this might be right forMelanomaNSCLCHepatocellular Carcinoma+5 more Dan Zandberg 72
Early research (Phase 1)Ended earlyNCT05909995What this trial is testingInterventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid TumorsWho this might be right forMelanomaHepatocellular Carcinoma (HCC)Renal Cell Carcinoma (RCC)+3 more Incyte Corporation 8
Testing effectiveness (Phase 2)Looking for participantsNCT06002789What this trial is testingSafety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCCWho this might be right forMultiple CancerColorectal Cancer Sixth Affiliated Hospital, Sun Yat-sen University 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05890742What this trial is testingA Clinical Trial Evaluating the Efficacy and Safety of IBI310 in Combination With Sintilimab, for Neoadjuvant Treatment of MSI-H/dMMR Resectable Colon CancerWho this might be right forMSI-H Innovent Biologics (Suzhou) Co. Ltd. 453
Large-scale testing (Phase 3)Active Not RecruitingNCT02997228What this trial is testingTesting the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT StudyWho this might be right forMetastatic Colorectal AdenocarcinomaStage IV Colorectal Cancer AJCC v7 National Cancer Institute (NCI) 120
Large-scale testing (Phase 3)Looking for participantsNCT06686576What this trial is testingNeoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon CancerWho this might be right forColon Cancer Qilu Pharmaceutical Co., Ltd. 363
Not applicableStudy completedNCT05162248What this trial is testingMicrosatellite Instability in Colorectal CancersWho this might be right forColorectal CancerColorectal CarcinomaMicrosatellite Instability High+2 more Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey 231
Testing effectiveness (Phase 2)Temporarily pausedNCT05337735What this trial is testingA Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare CancersWho this might be right forMicrosatellite High CancersPeritoneal MesotheliomaExtrapulmonary High Grade+5 more M.D. Anderson Cancer Center 140
Post-approval studies (Phase 4)Not Yet RecruitingNCT06897527What this trial is testingEvaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)Who this might be right forNeoplasms, Endometrial GlaxoSmithKline 100
Early research (Phase 1)Ended earlyNCT03866239What this trial is testingA Phase Ib Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Cibisatamab in Combination With Atezolizumab After Pretreatment With Obinutuzumab in Participants With Previously Treated Metastatic Colorectal AdenocarcinomaWho this might be right forColorectal Cancer Hoffmann-La Roche 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT04895722What this trial is testingEvaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008)Who this might be right forColorectal Cancer Merck Sharp & Dohme LLC 302
Early research (Phase 1)Ended earlyNCT04187872What this trial is testingLITT and Pembrolizumab in Recurrent Brain MetastasisWho this might be right forMelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more University of Florida 10
Testing effectiveness (Phase 2)Looking for participantsNCT02332668What this trial is testingPembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)Who this might be right forMelanomaLymphomaSolid Tumor+2 more Merck Sharp & Dohme LLC 370
Testing effectiveness (Phase 2)WithdrawnNCT06331598What this trial is testingAdjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors with Resectable Disease with Intermediate-High Risk of Recurrence and High Tumor Mutational Burden (TMB-H) or Microsatellite Instability (MSI-H)Who this might be right forSolid Tumors Hoffmann-La Roche
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07259473What this trial is testingFactors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric / Gastroesophageal Junction AdenocarcinomaMismatch Repair Deficient or MSI-High Solid TumorsImmunotherapy Shanghai Zhongshan Hospital 15